A capsid-modified adenovirus vector devoid of all viral genes: assessment of transduction and toxicity in human hematopoietic cells

作者: Hartmut Stecher , Dmitry M. Shayakhmetov , George Stamatoyannopoulos , André Lieber

DOI: 10.1006/MTHE.2000.0410

关键词:

摘要: Inefficient gene transfer has limited the success of therapy in hematopoietic system. Here we develop a novel chimeric adenovirus (Ad) vector containing Ad serotype 11 fiber-modified capsids and E1/E3 deleted viral genomes (Ad5/11) or devoid all genes (ΔAd5/11). The capsid-modified vectors transduced human cells more efficiently than unmodified Ad5-based vector. absence from ΔAd5/11 allowed for transduction without associated toxicity seen with first-generation Chimeric were used transient expression ecotropic retrovirus receptor (ecoR) Mo7e (a CD34-positive, c-Kit-positive, growth-factor-dependent cell line) as model progenitor cells. Expression ecoR conferred susceptibility to subsequent retroviral transduction. express expansion retrovirally cells, whereas Ad5/11 resulted cytotoxicity and, over time, loss expressing retrovirus-vector-derived transgene.

参考文章(49)
F. Garcia-Sanchez, G. Pizzorno, S.Q. Fu, T. Nanakorn, D.S. Krause, J. Liang, E. Adams, J.J. Leffert, L.H. Yin, M.R. Cooperberg, E. Hanania, W.L. Wang, J.H. Won, X.Y. Peng, R. Cote, R. Brown, B. Burtness, R. Giles, R. Crystal, A.B. Deisseroth, Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: A potential purging method for autologous transplantation Blood. ,vol. 92, pp. 672- 682 ,(1998) , 10.1182/BLOOD.V92.2.672
H. E. Broxmeyer, P. C. Hendrie, K. Miyazawa, Yu-Chung Yang, C. D. Langefeld, Mast cell growth factor (c-kit ligand) enhances cytokine stimulation of proliferation of the human factor-dependent cell line, M07e Experimental Hematology. ,vol. 19, pp. 1031- 1037 ,(1991)
RG Hawley, FH Lieu, AZ Fong, Teresa S Hawley, None, Versatile retroviral vectors for potential use in gene therapy. Gene Therapy. ,vol. 1, pp. 136- 138 ,(1994)
G J Rosman, A D Miller, Improved Retroviral Vectors for Gene Transfer and Expression BioTechniques. ,vol. 7, pp. 980- 990 ,(1989)
Peter Kurre, Hans-Peter Kiem, Julia Morris, Scott Heyward, Jean-Luc Battini, A. Dusty Miller, Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor Journal of Virology. ,vol. 73, pp. 495- 500 ,(1999) , 10.1128/JVI.73.1.495-500.1999
D Markowitz, S Goff, A Bank, A safe packaging line for gene transfer: separating viral genes on two different plasmids. Journal of Virology. ,vol. 62, pp. 1120- 1124 ,(1988) , 10.1128/JVI.62.4.1120-1124.1988
C Hesdorffer, J Ayello, M Ward, A Kaubisch, L Vahdat, C Balmaceda, T Garrett, M Fetell, R Reiss, A Bank, K Antman, Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. Journal of Clinical Oncology. ,vol. 16, pp. 165- 172 ,(1998) , 10.1200/JCO.1998.16.1.165
André Lieber, Dirk S. Steinwaerder, Cheryl A. Carlson, Mark A. Kay, Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes. Journal of Virology. ,vol. 73, pp. 9314- 9324 ,(1999) , 10.1128/JVI.73.11.9314-9324.1999